Kezar Life Sciences Inc (KZR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 41,749 | 35,493 | 40,456 | 62,882 | 21,228 |
| Marketable Securities | 90,496 | 165,879 | 236,105 | 145,473 | 119,219 |
| Other current assets | 0 | 0 | 0 | 729 | 1,631 |
| TOTAL | $137,488 | $206,950 | $285,722 | $211,654 | $144,811 |
| Non-Current Assets | |||||
| PPE Net | 2,893 | 3,912 | 3,431 | 3,283 | 3,435 |
| Other Non-Current Assets | 4,301 | 10,373 | 10,415 | 2,996 | 3,596 |
| TOTAL | $7,194 | $14,285 | $13,846 | $6,279 | $7,031 |
| Total Assets | $144,682 | $221,235 | $299,568 | $217,933 | $151,842 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,217 | 0 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 3,651 | 8,251 | 2,479 | 2,028 | 2,358 |
| Accrued Expenses | 7,935 | 6,481 | 5,953 | 4,985 | 3,021 |
| Other current liabilities | N/A | N/A | N/A | N/A | 21 |
| TOTAL | $20,329 | $17,744 | $10,997 | $8,212 | $6,442 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,111 | 10,069 | 9,834 | 9,622 | N/A |
| Other Non-Current Liabilities | 2,326 | 5,852 | 8,865 | 3,223 | 4,422 |
| TOTAL | $7,437 | $15,921 | $18,699 | $12,845 | $4,422 |
| Total Liabilities | $27,766 | $33,665 | $29,696 | $21,057 | $10,864 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,306 | 7,280 | 7,080 | 5,671 | 4,807 |
| Common Shares | 7 | 7 | 68 | 56 | 46 |
| Retained earnings | -434,499 | -350,763 | -248,893 | -180,654 | -126,024 |
| Other shareholders' equity | -162 | -130 | -923 | -291 | -137 |
| TOTAL | $116,916 | $187,570 | $269,872 | $196,876 | $140,978 |
| Total Liabilities And Equity | $144,682 | $221,235 | $299,568 | $217,933 | $151,842 |